Utility of advanced multiphoton imaging in detecting and quantifying renal fibrosis in renal biopsies of pediatric patients – A pilot study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2027
Project Lead
Dr. Arpana Iyengar
Authors
Dr. Arpana Iyengar, Dr. Priya Pais, Dr. Gnanapriya V Swaminathan
Project Status
ongoing
Project Type
In collaboration with IISc and Dept of Pathology (SJNAHS)